Growth and puberty in children with juvenile idiopathic arthritis
- PMID: 33712046
- PMCID: PMC7953722
- DOI: 10.1186/s12969-021-00521-5
Growth and puberty in children with juvenile idiopathic arthritis
Abstract
Juvenile Idiopathic Arthritis is one of the most prevalent chronic diseases in children, with an annual incidence of 2-20 cases per 100,000 and a prevalence of 16-150 per 100,000. It is associated with several complications that can cause short-term or long-term disability and reduce the quality of life. Among these, growth and pubertal disorders play an important role. Chronic inflammatory conditions are often associated with growth failure ranging from slight decrease in height velocity to severe forms of short stature. The prevalence of short stature in JIA varies from 10.4% in children with polyarticular disease to 41% of patients with the systemic form, while oligoarthritis is mostly associated with localized excessive bone growth of the affected limb, leading to limb dissymmetry. The pathogenesis of growth disorders is multifactorial and includes the role of chronic inflammation, long-term use of corticosteroids, undernutrition, altered body composition, delay of pubertal onset or slow pubertal progression. These factors can exert a systemic effect on the GH/IGF-1 axis and on the GnRH-gonadotropin-gonadic axis, or a local influence on the growth plate homeostasis and function. Although new therapeutic options are available to control inflammation, there are still 10-20% of patients with severe forms of the disease who show continuous growth impairment, ending in a short final stature. Moreover, delayed puberty is associated with a reduction in the peak bone mass with the possibility of concomitant or future bone fragility. Monitoring of puberty and bone health is essential for a complete health assessment of adolescents with JIA. In these patients, an assessment of the pubertal stage every 6 months from the age of 9 years is recommended. Also, linear growth should be always evaluated considering the patient's bone age. The impact of rhGH therapy in children with JIA is still unclear, but it has been shown that if rhGH is added at high dose in a low-inflammatory condition, post steroids and on biologic therapy, it is able to favor a prepubertal growth acceleration, comparable with the catch-up growth response in GH-deficient patients. Here we provide a comprehensive review of the pathogenesis of puberty and growth disorders in children with JIA, which can help the pediatrician to properly and timely assess the presence of growth and pubertal disorders in JIA patients.
Keywords: Bone; Growth; Hormone replacement therapy; Juvenile idiopathic arthritis; Puberty.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
Growth Failure in Children with Systemic Juvenile Idiopathic Arthritis and Prolonged Inflammation despite Treatment with Biologicals: Late Normalization of Height by Combined Hormonal Therapies.Horm Res Paediatr. 2018;90(5):337-343. doi: 10.1159/000489778. Epub 2018 Jun 25. Horm Res Paediatr. 2018. PMID: 29940586
-
Growth and the Growth Hormone-Insulin Like Growth Factor 1 Axis in Children With Chronic Inflammation: Current Evidence, Gaps in Knowledge, and Future Directions.Endocr Rev. 2016 Feb;37(1):62-110. doi: 10.1210/er.2015-1026. Epub 2015 Dec 31. Endocr Rev. 2016. PMID: 26720129 Review.
-
Growth abnormalities in children and adolescents with juvenile idiopathic arthritis.Rheumatol Int. 2014 Nov;34(11):1483-8. doi: 10.1007/s00296-014-3022-2. Epub 2014 Apr 24. Rheumatol Int. 2014. PMID: 24760485 Review.
-
Total pubertal growth in patients with juvenile idiopathic arthritis treated with growth hormone: analysis of a single center.Growth Horm IGF Res. 2012 Oct;22(5):180-5. doi: 10.1016/j.ghir.2012.07.002. Epub 2012 Jul 31. Growth Horm IGF Res. 2012. PMID: 22854327
-
Final height after combined growth hormone and gonadotrophin-releasing hormone analogue therapy in short healthy children entering into normally timed puberty.Clin Endocrinol (Oxf). 1998 Aug;49(2):197-202. doi: 10.1046/j.1365-2265.1998.00499.x. Clin Endocrinol (Oxf). 1998. PMID: 9828907 Clinical Trial.
Cited by
-
Identifying factors associated with substantially reduced adult height in patients with juvenile idiopathic arthritis: a retrospective cohort study.BMC Pediatr. 2024 May 30;24(1):375. doi: 10.1186/s12887-024-04855-3. BMC Pediatr. 2024. PMID: 38816849 Free PMC article.
-
Temporomandibular involvement in children and adolescents with juvenile idiopathic arthritis: a 2-year prospective cohort study.Sci Rep. 2024 Mar 6;14(1):5512. doi: 10.1038/s41598-024-56174-3. Sci Rep. 2024. PMID: 38448491 Free PMC article.
-
GH therapy in children with juvenile idiopathic arthritis: a four-decade review.Clin Pediatr Endocrinol. 2024;33(1):1-11. doi: 10.1297/cpe.2023-0036. Epub 2023 Dec 2. Clin Pediatr Endocrinol. 2024. PMID: 38299178 Free PMC article. Review.
-
Prospective study to characterize adalimumab exposure in pediatric patients with rheumatic diseases.Pediatr Rheumatol Online J. 2024 Jan 2;22(1):5. doi: 10.1186/s12969-023-00930-8. Pediatr Rheumatol Online J. 2024. PMID: 38167019 Free PMC article.
-
Gut microbiota in regulation of childhood bone growth.Exp Physiol. 2024 May;109(5):662-671. doi: 10.1113/EP091620. Epub 2023 Dec 29. Exp Physiol. 2024. PMID: 38156734 Free PMC article. Review.
References
-
- Petty RE, Southwood TR, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31(2):390–392. - PubMed
-
- Simon D, Fernando C, et al. Linear Growth and Final Height in Patients With Systemic Juvenile Idiopathic Arthritis Treated With Longterm Glucocorticoids. J Rheumatol. 2002;29(6):1296–1300. - PubMed
-
- MacRae VE, Wong SC, et al. Cytokine Actions in Growth Disorders Associated With Pediatric Chronic Inflammatory Diseases (Review) Int J Mol Med. 2006;18(6):1011–1018. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical